Progress and Gaps in Respiratory Disease Research and Treatment: Highlights of the IRM 2024 in Shanghai
Author Information
Author(s): Zhang Jin-San, Dhlamini Qhaweni, Guo Qiang, Quan Meiyu, Wu Jin, Lyu Handeng, Chong Lei, Lv Yuqing, Lin Yuting, Zhou Bin, Liu Yuru, Ji Honglong, Lin Xinhua, Ning Wen, Sui Pengfei, Chen Huaiyong, Gao Peisong, Chen Wei, Zhou Xiaobo, Song Yuanlin, Wang Chaoqun, Su Xiao, Xu Jinfu, Sun Jie, Chen Yin, Geng Yan, Song Hai, Ji Hongbin, Di Yuanpu Peter, Tang Hao, Lu Chao, Li Jinghong, Cheng Ke, Cao Mengshu, Liang Jiurong, Zhang Yingze, Zhou Yang, Xi Ying, Xiong Weining, Cao Bin, Que Jianwen, Jiang Dianhua
Conclusion
The insights gained from IRM2024 are poised to be pivotal in shaping future research and therapeutic approaches in respiratory health.
Supporting Evidence
- China has made notable strides in both research and clinical management of respiratory diseases.
- The International Respiratory Medicine (IRM) meeting facilitated the exchange of recent research developments.
- Key insights from IRM2024 highlighted advancements and challenges in respiratory science and clinical practice.
Takeaway
Researchers from around the world gathered to share new ideas and findings about lung diseases, aiming to improve treatments and patient care.
Methodology
The conference featured lectures and discussions on various topics related to respiratory diseases, integrating insights from basic, translational, and clinical research.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website